Free materials with details on the BRAF gene mutation test for dogs are available!
This document introduces the "BRAF gene mutation test for dogs (bladder transitional cell carcinoma and prostate cancer)" conducted by K9 Lab, which supports animal healthcare with advanced technology. In dogs with bladder transitional cell carcinoma and prostate cancer, mutations in the BRAF gene (homologous to human BRAF amino acid 600) are frequently present. In other tumors, the frequency of this mutation is low, and it is not detected in non-tumorous changes such as cystitis. Therefore, if a mutation is detected, it is highly likely that the cells in the sample are proliferating tumorally. The document provides detailed information on the characteristics of the test, its clinical significance, and a Q&A section. [Contents] ■ Characteristics of the test and clinical significance ■ Consider the BRAF gene mutation test in these situations ■ Evidence: Reference materials ■ Q&A *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog(1)
Download All CatalogsCompany information
K9 Lab Co., Ltd. is a company located in Koganei City, Tokyo, that conducts genetic testing for animals (dogs and cats), including mast cell tumors. Additionally, we also offer testing services for lymphoid tumors, treatment drug selection, infectious diseases, genetic disorders, and more. K9 Lab Co., Ltd. supports veterinary medicine with advanced technology.